In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist. - Test2 - elhamkhani - TriplyDB

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.

http://www.wikidata.org/entity/Q34322537

about

Functional evidence for a 5-HT2B receptor mediating contraction of longitudinal muscle in human small intestine Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist Effects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxiety In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties Recent advances in the neuropsychopharmacology of serotonergic hallucinogens Kynurenine potentiates the DOI head shake in mice m-Chlorophenylpiperazine decreases food intake in a test meal An immunocapture/scintillation proximity analysis of G alpha q/11 activation by native serotonin (5-HT)2A receptors in rat cortex: blockade by clozapine and mirtazapine 5-HT2C receptor modulation and the treatment of obesity.Citalopram-induced hypophagia is enhanced by blockade of 5-HT(1A) receptors: role of 5-HT(2C) receptors.The prevalence of female sexual dysfunction among migraine patients.Experimental studies on 3,4-methylenedioxymethamphetamine (MDA, "ecstasy") and its potential to damage brain serotonin neurons.Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area.Release of glutamate and CGRP from trigeminal ganglion neurons: Role of calcium channels and 5-HT1 receptor signaling Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology.Novel serotonin receptor 2 (5-HT2R) agonists and antagonists: a patent review (2004-2014).Multiple serotonin receptors: opportunities for new treatments for obesity?Multiple 5-HT receptors in the guinea-pig superior cervical ganglion Evidence for a role for central 5-HT2B as well as 5-HT2A receptors in cardiovascular regulation in anaesthetized rats.Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations.Latency to paroxetine-induced anxiolysis in the rat is reduced by co-administration of the 5-HT(1A) receptor antagonist WAY100635.Tolerance to 3,4-methylenedioxymethamphetamine is associated with impaired serotonin release.An investigation of the 5-HT2C receptor gene as a migraine candidate gene.Effects of the 5-HT2C receptor agonist meta-chlorophenylpiperazine on appetite, food intake and emotional processing in healthy volunteers.Effect of Hallucinogens on Unconditioned Behavior.Reversal of sibutramine-induced anorexia with a selective 5-HT(2C) receptor antagonist.Effect of combined administration of afobazole and 5-HT2b/2c receptor antagonist SB-200646A on neurochemical profile of brain structures in C57Bl/6 and BALB/c mice.Role of atypical opiates in OCD. Experimental approach through the study of 5-HT(2A/C) receptor-mediated behavior.The acute and chronic administration of the 5-HT(2B/2C) receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: An in vivo extracellular single cell study.The role of 5-HT2C receptors in affective disorders.Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety.In vivo Schild regression analyses using nonselective 5-HT2C receptor antagonists in a rat operant behavioral assay.Effects of ritanserin and 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the murine elevated plus-maze test of anxiety: an ethopharmacological study.

P2860

Q24317175-CDD3CC8E-DA38-4F90-879A-F477279C5E19 Q24595389-A621680E-2E1B-4004-8D0D-F65E3FAA0B2F Q24672386-EB2072A4-9672-4820-9732-6BC20FCA0133 Q24679647-1EB7E7AE-0B1C-4A9C-A9A9-33BC52FC3DC8 Q24679694-A4EC5AB0-B326-49C0-A5CF-3B9CD90E8650 Q27027381-4A11A9EB-7104-44C2-AD13-B021836B86E0 Q28258717-2FC15C2E-037A-416F-931D-990E25AACDD1 Q28307494-3D2B0D51-8DA1-4CE3-9577-E9E5909D95B7 Q28578911-9F84EDB5-23A8-4569-962B-3BABFEE8F826 Q33936081-18B1549D-DC07-41E5-B031-295875CAEDB3 Q35027938-747C3C6E-07A0-4ED9-AFB4-9F9D09F36B71 Q35399494-DFAF1B94-6148-4AC8-B3CD-7BD64D036773 Q35757409-4A5FEE9D-DDD2-472C-9A8E-8B249C55F5D2 Q35873019-3EDA959D-0DDD-4F47-B6E5-916545D12F55 Q36608907-3F941EBC-6D94-42C5-A2C1-215ABCE9B210 Q38101499-B5B9B91E-0BE8-4310-9182-968ABED686A9 Q38648544-7921FF9D-2035-4600-9F36-9A2E2A860BCA Q41026153-91D315C0-6B02-4116-BC4D-2E7790B910BD Q41908786-9F6EF9B4-2C08-4FFF-8FBC-4FD03725A5F6 Q41985535-0483E1B5-F3C7-4E24-8B1A-C3504F4B7719 Q42057930-9CCFD239-A9E7-45AB-A5F2-BDA174E99287 Q42220908-970C5A45-9AE4-4CE5-B944-BC902C509F58 Q42237452-951735A9-F91D-4C3D-B4E0-D832CF195214 Q43061538-8632E478-0E38-4D9B-B1E0-D5754DDF010E Q44295040-1B9C45A6-8255-4639-9BA6-035649967348 Q44992845-DE052C59-5533-4E7B-A61E-735AB77AF2B5 Q45279141-0AE90C4A-6B72-46B7-9A26-63E847B9C434 Q45908028-C10D9961-1CF5-40C5-A24A-6259FF97FEA1 Q48313857-DEABE0FA-A808-47AF-83BC-AF2863C37D6D Q48370760-B204F976-1178-4B4D-B224-73A297390E4C Q48604122-E59CC838-793B-4180-B977-CFF754BE1C46 Q48826724-85E178F6-BC08-4E8A-B39D-94422A39B285 Q51126109-F350BD9B-06C0-4666-ACD1-48258D2BBA90 Q51990165-0FE36A29-4DB1-4A5B-ACC8-B2F81CDF39E2 Q52870855-D4A19481-CA4A-4E88-BFCD-FEB34FB172BA

P2860

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.

http://www.wikidata.org/entity/Q34322537

description

1994 nî lūn-bûn

@nan

1994 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի մարտին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.

@ast

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.

@en

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.

@nl

type

label

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.

@ast

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.

@en

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.

@nl

prefLabel

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.

@ast

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.

@en

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.

@nl

P1433

Q34322537-04C2761A-125E-45CF-9922-8E0DB23CF5B2

P1476

Q34322537-340E0DD9-F26C-4393-89CF-D6AE6D585F3F

P2093

Q34322537-0432B1DC-D0C1-4297-B32B-FEFB63DDA6E7

Q34322537-63E7346C-D63B-4D65-AA17-749D5FE3FAC6

Q34322537-6F83576E-0F44-4671-A625-1E1BE2B93173

Q34322537-7AC3D875-3778-4487-A6BB-353FF6E23B58

Q34322537-B3790D87-BA8D-4516-A1D2-B1FD113AC5A7

Q34322537-DAA41F9A-7507-4236-BD1E-8CF3502A3730

Q34322537-E501AC74-6A97-4283-9006-ED2BE16B0533

P2860

Q34322537-02ECB393-D3FC-43B6-8B15-39205F52C9D6

Q34322537-048B0F77-9E79-4C69-B348-7ECD3C88E79B

Q34322537-14E60888-DF1A-4662-9312-27A86E2F9241

Q34322537-24196473-8B87-40C8-A244-2AF2C71BF19A

Q34322537-31A5BB85-ADAD-4F3D-8DD5-C354708B5353

Q34322537-38B4E7C6-95C6-4ECD-ACA0-B4C97C01D853

Q34322537-39816CE5-8B22-4C26-8008-F46175E3FCA8

Q34322537-3D22E492-0AD2-4A09-BB92-B2FE1196A115

Q34322537-422C72E1-484B-462B-9342-2AEAFE4FC0F0

Q34322537-4F0804D0-BE8C-4AAF-BDA7-27663FE90129

P304

Q34322537-BCFE91BB-00A4-4977-A81E-F7FE9DE1C968

P31

Q34322537-803A2CD7-BAB1-4CC0-B83E-E59C985B7019

P356

Q34322537-C6242C10-5376-4605-9C8B-F8F13A346A36

P407

Q34322537-29513E51-2588-4D1A-B5EF-0F8CF179029F

P433

Q34322537-F103868C-AEDA-4409-B5F7-B6319FE8BDC5

P478

Q34322537-5EA93838-81AD-4182-89FC-742DF2D73DE8

P577

Q34322537-CD4269F5-6E99-4364-9B07-BE16E618E9F1

P5875

Q34322537-98C3613E-89C4-4D39-8556-A2C6134C0D01

P698

Q34322537-410E920B-5F8C-4A37-998A-4CA653AA41EC

P932

Q34322537-2173A3C1-CF46-416D-B948-1DECB31C0898

P356

J.1476-5381.1994.TB14808.X

P1433

British Journal of Pharmacology

P1476

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.

@en

P2093

Blackburn TP

http://www.w3.org/2001/XMLSchema#string

Forbes I

http://www.w3.org/2001/XMLSchema#string

Gadre A

http://www.w3.org/2001/XMLSchema#string

Glen A

http://www.w3.org/2001/XMLSchema#string

Grewal S

http://www.w3.org/2001/XMLSchema#string

Kennett GA

http://www.w3.org/2001/XMLSchema#string

Wood MD

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors

Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder

Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists

Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes

Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors

Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus

Structure of the mouse 5-HT1C, 5-HT2 and stomach fundus serotonin receptor genes.

New mouse 5-HT2-like receptor. Expression in brain, heart and intestine.

5-HT1C receptor antagonists have anxiolytic-like actions in the rat social interaction model.

5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system

P304

797-802

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1476-5381.1994.TB14808.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

1994-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15285859

http://www.w3.org/2001/XMLSchema#string

P698

7912626

http://www.w3.org/2001/XMLSchema#string

P932

1910094

http://www.w3.org/2001/XMLSchema#string